🇺🇸 FDA
Patent

US 10525120

Methods and compositions for live attenuated viruses

granted A61KA61K2039/5254A61K2039/55555

Quick answer

US patent 10525120 (Methods and compositions for live attenuated viruses) held by Takeda Vaccines, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/5254, A61K2039/55555, A61K2039/70, A61K39/12